Sponsored By

Pixium Vision Is Setting its Sights on Finding a Buyer

The Paris, France-based company announced the measure because it was unable to find financial investors within a restricted timeframe.

Omar Ford

October 23, 2023

1 Min Read
IMG_2023-10-23-152841.jpg
Image Credit: Dimitri Otis/Getty Images

Pixium Vision is looking for a buyer a little more than two years after ending a deal to acquire Second Sight Medical Products.

Last week, the Paris, France-based company and maker of bionic eye implants announced the launch of a process to find buyers. The company said it was undertaking this measure because it could not find financial investors within the restricted timeframe and in line with its needs.

The company said the deadline for submission of offers has been set by the court-appointed administrators to November 20, 2023 at 12:00 p.m.

Earlier this year, Pixium won breakthrough device designation for the Prima System, an implant to help treat dry age-related macular degeneration.

The designation came at a time when Pixium was well-removed from a merger attempt with Second Sight Medical Products. Pixium terminated plans to acquire the Second Sight company because the Sylmar, CA-based company filed for a private placement of $27.9 million. Pixium noted that placement violated the memorandum of understanding between the two.

Second Sight would go on to merge with Nano Precision Medical to be rebranded as Vivani Medical.

About a year after the merger plans were put on halt, a Paris Commercial Court ordered the merged company to pay Pixium $1.68 million for violating the MoU.

 

About the Author(s)

Omar Ford

Omar Ford is MD+DI's Editor-in-Chief. You can reach him at [email protected].

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like